The S100A2, which is a protein in humans also known as CaN19, has an expression that's reduced in many cancers along with being down-regulated in melanoma.
The S100A2, which is a protein in humans also known as CaN19, has an expression that's reduced in many cancers along with being down-regulated in melanoma.